Stocktoria
Bio Essence Corp BIOE
OTC · stock · Pharmaceutical Preparations · website · IPO 2022-03-30
Bio Essence Corp statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 75.3% | 67.0% | 50.3% | 52.8% | 33.6% | 23.7% |
| Operating margin | 47.4% | -141.8% | -62.7% | -82.2% | -96.6% | -86.8% |
| Net margin | 47.2% | -404.0% | -176.2% | -130.3% | -72.9% | -62.2% |
| FCF margin | — | — | -186.6% | -113.7% | -159.2% | -77.2% |
| Return on assets | 212.1% | -465.7% | -35.2% | -52.3% | -38.1% | -32.3% |
| Return on equity | -43.2% | 44.1% | 58.5% | 25.0% | 26.7% | 33.5% |
| Debt / equity | -0.03× | -0.02× | — | — | — | — |
| Current ratio | 0.17 | 0.10 | 0.12 | 0.06 | 0.10 | 0.17 |
Source: SEC EDGAR filings · CIK 0001723059 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.